Center for the Assessment of Pharmaceutical Practices

URI: http://hdl.handle.net/2144/2464

An alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia in the Veterans Health Administration

Ren, Xinhua S.; Qian, Shirley; Kazis, Lewis E. (Dove Medical Press, 2007)

Prior studies have demonstrated the importance of treatment persistence with anti-psychotic agents in sustaining control of schizophrenic symptoms. However, the conventional approach in measuring treatment persistence ...
Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia

Ren, Xinhua S.; Herz, Lawrence; Qian, Shirley; Smith, Eric; Kazis, Lewis E. (Dove Medical Press, 2009-10-12)

The importance of medication adherence in sustaining control of schizophrenic symptoms has generated a great deal of interest in comparing levels of treatment adherence with different antipsychotic agents. However, the ...
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

Wolozin, Benjamin; Wang, Stanley W.; Li, Nien-Chen; Lee, Austin; Lee, Todd A.; Kazis, Lewis E. (BioMed Central, 2007-7-19)

BACKGROUND: Statins are a class of medications that reduce cholesterol by inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Whether statins can benefit patients with dementia remains unclear because of conflicting ...